Contessa Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model
Contessa Health, a subsidiary of Amedisys Inc. (Nasdaq: AMED), has been selected by the Centers for Medicare & Medicaid Services (CMS) to participate in the Guiding an Improved Dementia Experience (GUIDE) Model. This new Medicare alternative payment model aims to support people living with dementia and their caregivers. As one of nearly 400 participants, Contessa will build Dementia Care Programs (DCPs) to enhance care coordination and improve access to services.
The GUIDE Model, launched on July 1, 2024, will test a new payment approach for key supportive services, including comprehensive assessments, care coordination, 24/7 access to care team members, and respite services. Contessa's participation will provide dementia patients and caregivers with access to education, support, and respite services, potentially allowing them to live at home longer and achieve a better quality of life.
Contessa Health, una filiale di Amedisys Inc. (Nasdaq: AMED), è stata selezionata dai Centers for Medicare & Medicaid Services (CMS) per partecipare al Modello GUIDARE un Miglioramento dell'Esperienza con la Demenza (GUIDE). Questo nuovo modello di pagamento alternativo per Medicare ha l'obiettivo di supportare le persone con demenza e i loro caregiver. Come uno dei quasi 400 partecipanti, Contessa svilupperà Programmi di Cura per la Demenza (DCP) per migliorare il coordinamento delle cure e facilitare l'accesso ai servizi.
Il Modello GUIDE, lanciato il 1° luglio 2024, testerà un nuovo approccio ai pagamenti per servizi di supporto chiave, inclusi valutazioni complete, coordinamento delle cure, accesso 24 ore su 24 a membri del team di assistenza e servizi di sollievo. La partecipazione di Contessa fornirà ai pazienti con demenza e ai caregiver accesso a istruzione, supporto e servizi di sollievo, permettendo loro di vivere a casa più a lungo e di raggiungere una qualità della vita migliore.
Contessa Health, una subsidiaria de Amedisys Inc. (Nasdaq: AMED), ha sido seleccionada por los Centros de Servicios de Medicare y Medicaid (CMS) para participar en el Modelo Guiar una Experiencia Mejorada de Demencia (GUIDE). Este nuevo modelo de pago alternativo de Medicare tiene como objetivo apoyar a las personas que viven con demencia y a sus cuidadores. Como uno de los casi 400 participantes, Contessa desarrollará Programas de Cuidado de Demencia (DCP) para mejorar la coordinación del cuidado y facilitar el acceso a los servicios.
El Modelo GUIDE, lanzado el 1 de julio de 2024, pondrá a prueba un nuevo enfoque de pago para servicios de apoyo clave, incluyendo evaluaciones integrales, coordinación del cuidado, acceso 24/7 a miembros del equipo de atención y servicios de descanso. La participación de Contessa proporcionará a los pacientes con demencia y a los cuidadores acceso a educación, apoyo y servicios de descanso, permitiéndoles vivir en casa durante más tiempo y lograr una mejor calidad de vida.
Contessa Health는 Amedisys Inc. (Nasdaq: AMED)의 자회사로, Medicare 및 Medicaid 서비스 센터(CMS)에 의해 개선된 치매 경험 안내 모델(GUIDE)에 참여하도록 선택되었습니다. 이 새로운 Medicare 대체 지불 모델은 치매를 앓고 있는 사람들과 그들의 간병인을 지원하는 것을 목표로 합니다. 거의 400명의 참가자 중 하나로서, Contessa는 치료 조정 향상과 서비스 접근을 개선하기 위해 치매 케어 프로그램(DCP)을 구축할 것입니다.
2024년 7월 1일에 시작되는 GUIDE 모델은 종합 평가, 치료 조정, 24시간 치료 팀 구성원에 대한 접근 및 휴식 서비스 등 핵심 지원 서비스에 대한 새로운 지불 접근 방식을 시험할 것입니다. Contessa의 참여는 치매 환자와 간병인에게 교육, 지원 및 휴식 서비스에 접근할 수 있게 하여, 그들이 더 오래 집에서 살고 더 나은 삶의 질을 누릴 수 있도록 할 것입니다.
Contessa Health, une filiale de Amedisys Inc. (Nasdaq: AMED), a été sélectionnée par les Centers for Medicare & Medicaid Services (CMS) pour participer au Modèle de Guidage d'une Expérience Améliorée de la Démence (GUIDE). Ce nouveau modèle de paiement alternatif pour Medicare vise à soutenir les personnes vivant avec la démence et leurs aidants. En tant que l'un des près de 400 participants, Contessa mettra en place des Programmes de Soins pour la Démence (DCP) pour améliorer la coordination des soins et faciliter l'accès aux services.
Le Modèle GUIDE, lancé le 1er juillet 2024, testera une nouvelle approche de paiement pour des services de soutien clés, notamment des évaluations complètes, la coordination des soins, un accès 24 heures sur 24 et 7 jours sur 7 aux membres de l'équipe de soins et des services de répit. La participation de Contessa fournira aux patients souffrant de démence et à leurs aidants un accès à l'éducation, au soutien et aux services de répit, leur permettant potentiellement de vivre plus longtemps chez eux et d'améliorer leur qualité de vie.
Contessa Health, eine Tochtergesellschaft von Amedisys Inc. (Nasdaq: AMED), wurde von den Centers for Medicare & Medicaid Services (CMS) ausgewählt, um am Modell zur Verbesserung der Demenzerfahrung (GUIDE) teilzunehmen. Dieses neue alternatives Zahlungsmodell für Medicare zielt darauf ab, Menschen mit Demenz und ihren Pflegekräften zu unterstützen. Als einer von fast 400 Teilnehmern wird Contessa Demenzpflegeprogramme (DCPs) aufbauen, um die Koordination der Pflege zu verbessern und den Zugang zu Dienstleistungen zu erleichtern.
Das GUIDE-Modell, das am 1. Juli 2024 gestartet wird, wird einen neuen Zahlungsansatz für wichtige Unterstützungsleistungen testen, einschließlich umfassender Bewertungen, Pflegekoordination, rund um die Uhr Zugang zu Mitgliedern des Betreuungsteams und Entlastungsdiensten. Die Teilnahme von Contessa wird es Demenzpatienten und deren Pflegekräften ermöglichen, Zugang zu Bildung, Unterstützung und Entlastungsdiensten zu erhalten, was ihnen möglicherweise erlaubt, länger zu Hause zu leben und eine höhere Lebensqualität zu erreichen.
- Contessa selected as participant in CMS's GUIDE Model, potentially expanding its service offerings
- Opportunity to tap into the growing dementia care market
- Alignment with government initiatives may lead to increased visibility and potential future collaborations
- Implementation of new care programs may require significant resources and investment
- Success of the GUIDE Model is yet to be proven, posing potential risks
Insights
The selection of Contessa Health for CMS's GUIDE Model represents a significant shift in Medicare's approach to dementia care. This initiative aims to enhance care coordination and support for dementia patients and their caregivers, potentially reducing institutional care needs. The model's focus on comprehensive assessments, 24/7 access to care teams and respite services could substantially improve quality of life for patients while reducing caregiver strain.
From a policy perspective, this move aligns with broader healthcare trends towards value-based care and home-based services. The inclusion of respite care is particularly noteworthy, as it addresses a critical gap in current Medicare coverage. If successful, this model could pave the way for more comprehensive Medicare coverage of dementia care services, potentially reducing long-term costs associated with institutional care.
Contessa Health's participation in the GUIDE Model presents a positive opportunity for Amedisys Inc. (AMED), its parent company. This initiative could open up a new revenue stream in the growing dementia care market. With the aging population, demand for these services is likely to increase, positioning Amedisys for potential long-term growth.
However, investors should note that the financial impact may not be immediate. As a test model, it will take time to assess its effectiveness and profitability. The success of this program could influence future Medicare reimbursement policies, potentially benefiting companies like Amedisys that are early adopters. While this news is positive, it's important to consider it as part of a broader investment thesis, factoring in Amedisys's overall financial health and market position.
The GUIDE Model represents a significant advancement in dementia care. By providing comprehensive, person-centered care plans and 24/7 access to interdisciplinary teams, it addresses important gaps in current care models. The inclusion of Care Navigators is particularly valuable, as navigating healthcare systems can be overwhelming for dementia patients and caregivers.
The focus on caregiver support, including respite services, is a critical component often overlooked in traditional care models. This holistic approach could potentially delay institutionalization, improving patient outcomes and quality of life. However, the success of this model will largely depend on effective implementation and coordination among various healthcare providers. It will be important to monitor how Contessa Health and other participants translate this model into practical, effective care delivery.
Guiding an Improved Dementia Experience (GUIDE) Model Aims to Increase Care Coordination, Support for Caregivers
NASHVILLE, Tenn., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Today, Contessa Health, a subsidiary of Amedisys Inc. (Nasdaq: AMED), announced they have been selected by the Centers for Medicare & Medicaid Services (CMS) to participate in a new Medicare alternative payment model designed to support people living with dementia and their caregivers. Under CMS’ Guiding an Improved Dementia Experience (GUIDE) Model, Contessa will be one of almost 400 participants building Dementia Care Programs (DCPs) across the country, working to increase care coordination and improve access to services and supports, including respite care, for people living with dementia and their caregivers.
“CMS is excited to partner with Contessa under the GUIDE Model,” said CMS Administrator Chiquita Brooks-LaSure. “GUIDE is a new approach to how Medicare will pay for the care of people living with dementia. The GUIDE participants are envisioning new ways to support not only people living with dementia, but also to reduce strain on the people who care for them, so that more Americans can remain in their homes and communities, rather than in institutions.”
Launched on July 1, 2024, the GUIDE Model will test a new payment approach for key supportive services furnished to people living with dementia, including: comprehensive, person-centered assessments and care plans; care coordination; 24/7 access to an interdisciplinary care team member or help line; and certain respite services to support caregivers. People with dementia and their caregivers will have the assistance and support of a Care Navigator to help them access clinical and non-clinical services such as meals and transportation through community-based organizations.
“Our team of nurse practitioners, nurses, and social workers have tremendous experience in helping patients and caregivers navigate through the complex world of healthcare. Through the GUIDE Model, we are able to apply this clinical model for dementia patients and their caregivers to allow this vulnerable population to be able to live at home longer and achieve a better quality of life,” said Gavin Baumgardner, DO, MHA, Contessa’s Vice President and National Medical Director of Palliative Care at Home.
Contessa’s participation in the GUIDE Model will help people living with dementia and their caregivers have access to education and support, such as training programs on best practices for caring for a loved one living with dementia. The GUIDE Model also provides respite services for certain people, enabling caregivers to take temporary breaks from their caregiving responsibilities. Respite is being tested under the GUIDE Model to assess its effect on helping caregivers continue to care for their loved ones at home, preventing or delaying the need for facility care.
GUIDE Participants represent a wide range of health care providers, including large academic medical centers, small group practices, community-based organizations, health systems, hospice agencies, and other practices.
This model delivers on a promise in the Biden Administration’s Executive Order on Increasing Access to High-Quality Care and Supporting Caregivers and aligns with the National Plan to Address Alzheimer’s Disease. For more information on CMS’ GUIDE Model, please visit: https://www.cms.gov/priorities/innovation/innovation-models/guide.
About Contessa Health:
Contessa, an Amedisys company, delivers comprehensive care at home. An industry pioneer since 2015, Contessa provides a coordinated suite of services including Recovery Care at Home, in lieu of being admitted to a hospital, Rehabilitation Care at Home, in lieu of being admitted to a skilled nursing facility, and Palliative Care at Home. Combining all the essential elements of an inpatient hospital or rehabilitation stay into the comfort of patients’ homes, Contessa allows partners to reimagine care delivery. Contessa utilizes Care Convergence™, a proprietary technology platform, to power a seamless solution that is safe, affordable and improves patient outcomes. Based in Nashville, the company currently partners with 11 health systems and multiple health plans serving patients in nine states. Contessa has the ability to serve more patients in a full care continuum, from primary care to end-of-life, all in the comfort of home. For more information, visit contessahealth.com or follow us at @contessahealth.
About Amedisys:
Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and high-acuity care services. Amedisys is focused on delivering the care that is best for our patients, whether that is inpatient hospital, palliative, and skilled nursing facility (“SNF”) care in their homes; home-based recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. Nearly 3,000 hospitals and more than 110,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With approximately 19,000 employees in 521 care centers in 37 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of nearly 470,000 patients in need every year, performing more than 10.6 million visits annually. For more information about the Company, please visit: www.amedisys.com.
| Contact: | |
| Nick Muscato Amedisys, Inc. Chief Strategy Officer 615.928.5452 nick.muscato@amedisys.com | Kendra Kimmons Amedisys, Inc. Media Relations 225.299.3720 kendra.kimmons@amedisys.com |
FAQ
What is the GUIDE Model that Contessa Health (AMED) is participating in?
How will Contessa's participation in the GUIDE Model benefit dementia patients and caregivers?
What services will be offered under the GUIDE Model that Contessa (AMED) is participating in?
When did the GUIDE Model, which Contessa Health (AMED) is participating in, launch?
